These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
523 related items for PubMed ID: 9351506
21. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Radovits T, Seres L, Gero D, Lin LN, Beller CJ, Chen SH, Zotkina J, Berger I, Groves JT, Szabó C, Szabó G. Mech Ageing Dev; 2007 Feb; 128(2):173-81. PubMed ID: 17116320 [Abstract] [Full Text] [Related]
22. Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity. Bai P, Hegedus C, Erdélyi K, Szabó E, Bakondi E, Gergely S, Szabó C, Virág L. Toxicol Lett; 2007 May 15; 170(3):203-13. PubMed ID: 17428624 [Abstract] [Full Text] [Related]
23. Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5'-diphosphoribose) synthase. Chabot F, Mitchell JA, Quinlan GJ, Evans TW. Br J Pharmacol; 1997 Jun 15; 121(3):485-90. PubMed ID: 9179390 [Abstract] [Full Text] [Related]
24. Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase. Mazzon E, De Sarro A, Caputi AP, Cuzzocrea S. Shock; 2002 Nov 15; 18(5):434-9. PubMed ID: 12412622 [Abstract] [Full Text] [Related]
25. Direct effect of dexmedetomidine on rat isolated aorta involves endothelial nitric oxide synthesis and activation of the lipoxygenase pathway. Kim HJ, Sohn JT, Jeong YS, Cho MS, Kim HJ, Chang KC, Shin MK, Park CS, Chung YK. Clin Exp Pharmacol Physiol; 2009 Apr 15; 36(4):406-12. PubMed ID: 19018801 [Abstract] [Full Text] [Related]
26. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Zingarelli B, Haskó G, Salzman AL, Szabó C. Crit Care Med; 1999 Sep 15; 27(9):1701-7. PubMed ID: 10507586 [Abstract] [Full Text] [Related]
27. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779 [Abstract] [Full Text] [Related]
28. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase. Bonaventura D, Lunardi CN, Rodrigues GJ, Neto MA, Vercesi JA, de Lima RG, da Silva RS, Bendhack LM. J Inorg Biochem; 2009 Oct 21; 103(10):1366-74. PubMed ID: 19699534 [Abstract] [Full Text] [Related]
29. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester. López RM, Ortíz CS, Ruíz A, Vélez JM, Castillo C, Castillo EF. Fundam Clin Pharmacol; 2004 Dec 21; 18(6):669-77. PubMed ID: 15548238 [Abstract] [Full Text] [Related]
30. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite. Radovits T, Zotkina J, Lin LN, Bömicke T, Arif R, Gerö D, Horváth EM, Karck M, Szabó C, Szabó G. Exp Biol Med (Maywood); 2007 Oct 21; 232(9):1204-12. PubMed ID: 17895528 [Abstract] [Full Text] [Related]
31. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Welch GN, Upchurch GR, Farivar RS, Pigazzi A, Vu K, Brecher P, Keaney JF, Loscalzo J. Proc Assoc Am Physicians; 1998 Oct 21; 110(1):22-31. PubMed ID: 9460080 [Abstract] [Full Text] [Related]
32. Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta. Deng HF, Xiong Y. Acta Pharmacol Sin; 2005 Jan 21; 26(1):92-8. PubMed ID: 15659120 [Abstract] [Full Text] [Related]
33. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Payá M, García Pastor P, Coloma J, Alcaraz MJ. Br J Pharmacol; 1997 Apr 21; 120(8):1445-52. PubMed ID: 9113364 [Abstract] [Full Text] [Related]
34. Agonist-induced peroxynitrite production from endothelial cells. Kooy NW, Royall JA. Arch Biochem Biophys; 1994 May 01; 310(2):352-9. PubMed ID: 8179319 [Abstract] [Full Text] [Related]
35. Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation. Tasatargil A, Tekcan M, Celik-Ozenci C, Ece Gungor N, Dalkiran B. J Renin Angiotensin Aldosterone Syst; 2009 Sep 01; 10(3):127-37. PubMed ID: 19713411 [Abstract] [Full Text] [Related]
36. Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide. Cena J, Lalu MM, Rosenfelt C, Schulz R. Eur J Pharmacol; 2008 Mar 17; 582(1-3):116-22. PubMed ID: 18242597 [Abstract] [Full Text] [Related]
37. Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability. Cuzzocrea S, Mazzon E, De Sarro A, Caputi AP. Mol Med; 2000 Sep 17; 6(9):766-78. PubMed ID: 11071271 [Abstract] [Full Text] [Related]
38. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Virág L, Scott GS, Cuzzocrea S, Marmer D, Salzman AL, Szabó C. Immunology; 1998 Jul 17; 94(3):345-55. PubMed ID: 9767416 [Abstract] [Full Text] [Related]
39. Temporal relationships between levels of circulating NO derivatives, vascular NO production and hyporeactivity to noradrenaline induced by endotoxin in rats. Paya D, Maupoil V, Schott C, Rochette L, Stoclet JC. Cardiovasc Res; 1995 Dec 17; 30(6):952-9. PubMed ID: 8746211 [Abstract] [Full Text] [Related]
40. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. Cuzzocrea S, Zingarelli B, Costantino G, Sottile A, Teti D, Caputi AP. Crit Care Med; 1999 Aug 17; 27(8):1517-23. PubMed ID: 10470759 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]